Germany Drug Delivery Devices Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 7.60 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Germany Drug Delivery Devices Market Analysis
The Germany Drug Delivery Devices market is expected to register a 7.6% CAGR during the forecast period. Some of the primary factors that are responsible for the tremendous growth of this market are the growing burden of chronic disorders in the country and advancing technology in drug delivery devices.
Germany has presence of all the major pharmaceuticals and biotechnology companies. The companies are constantly taking initiatives to introduce new products in order to grow their presence in the market. For instance, in July 2019, Sensile Gerresheimer subsidiary Sensile Medical developed "D Mine Pump" which is a wearable microinfusion pump and used for administering apomorphine in the Parkinson's treatment. Thus, owing to such innovations the market is expected to boost over the forecast period. However, the manufacturing of a complex drug delivery system is quite lengthy which might have a negative impact on the market.
Germany Drug Delivery Devices Market Trends
This section covers the major market trends shaping the Germany Drug Delivery Devices Market according to our research experts:
Cancer is Expected to Show a Significant Growth in the Market during the Forecast Period
Cancer in the applications segment is expected to contribute significantly to the growth of the market, owing to factors such as the rising number of cancer cases being reported in the country. According to the estimates of the Globocan 2018, there are about 608,742 new cases of cancer in Germany. While five most frequent cancers include breast, lung, prostate, colorectum, and bladder cancer. Due to this high prevalence of cancer, increasing efforts are being made in R&D for the development of novel drug delivery systems for providing a better treatment in the patients. The use of innovative technologies in drug deliveries for cancer treatment is driving the market in this segment.
Drug delivery systems like nano-size structures-based pharmaceutical formulations (e.g., liposomes, polymeric nanoparticles, electrosprayed particles, and nanosuspension) have demonstrated shown better administration of drugs in case of cancer treatment. Thus, overall a positive growth is expected in this segment during the forecast period.
Germany Drug Delivery Devices Industry Overview
Some of the companies which are currently dominating the Germany Drug Delivery Devices market are Pfizer Inc., 3M, Phillips-Medisize - a Molex Company, Novartis AG, Novaliq GmbH, Acino International AG, Bayer AG and Boehringer Ingelheim. In March 2019, Boehringer Ingelheim acquired ICD Therapeutics for the company's MacroDel biologics-delivery platform. This is expected to open up opportunities for the treatment of cancers that are difficult to treat.
Germany Drug Delivery Devices Market Leaders
-
Novartis AG
-
Novaliq GmbH
-
Acino International AG
-
Bayer AG
-
Pfizer Inc.
*Disclaimer: Major Players sorted in no particular order
Germany Drug Delivery Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Burden of Chronic Diseases
- 4.2.2 Technological Advancements in Drug Delivery Devices
-
4.3 Market Restraints
- 4.3.1 Complex Manufacturing Process of Products
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Route of Administration
- 5.1.1 Topical
- 5.1.2 Injectable
- 5.1.3 Oral
- 5.1.4 Others
-
5.2 By Application
- 5.2.1 Cancer
- 5.2.2 Cardiovascular
- 5.2.3 Diabetes
- 5.2.4 Others
-
5.3 By End Users
- 5.3.1 Hospitals
- 5.3.2 Ambulatory Surgical Centres
- 5.3.3 Others
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Pfizer Inc.
- 6.1.2 3M Company
- 6.1.3 Phillips-Medisize - a Molex Company
- 6.1.4 Novartis AG
- 6.1.5 Novaliq GmbH
- 6.1.6 Acino International AG
- 6.1.7 Bayer AG
- 6.1.8 Boehringer Ingelheim
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityGermany Drug Delivery Devices Industry Segmentation
As per the scope, drug delivery devices or system are the tools which are used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. The Germany Drug Delivery Devices Market is segmented By Route of Administration, Application, and End User.
Germany Drug Delivery Devices Market Research FAQs
What is the current Germany Drug Delivery Devices Market size?
The Germany Drug Delivery Devices Market is projected to register a CAGR of 7.60% during the forecast period (2024-2029)
Who are the key players in Germany Drug Delivery Devices Market?
Novartis AG, Novaliq GmbH, Acino International AG, Bayer AG and Pfizer Inc. are the major companies operating in the Germany Drug Delivery Devices Market.
What years does this Germany Drug Delivery Devices Market cover?
The report covers the Germany Drug Delivery Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Germany Drug Delivery Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Germany Drug Delivery Devices Industry Report
Statistics for the 2024 Germany Drug Delivery Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Germany Drug Delivery Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
